Evidence mapPaperPMID 39359152Full record

ArticleBJPsych open2024

Understanding the medication regimens associated with anticholinergic burden in older people's mental health services in the UK.

Thomas R E Barnes, Delia Bishara, Alistair Burns, Phyo K Myint, Olivia Rendora, Elena M Edokpolor Pernia, Carol Paton

Abstract read
In one paragraph

Article in BJPsych open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Observational
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Thomas R E BarnesDivision of Psychiatry, Imperial College London, London, UK.ORCID https://orcid.org/0000-0002-2324-656X
Delia BisharaInstitute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.ORCID https://orcid.org/0000-0002-6254-2054
Alistair BurnsDivision of Neuroscience, University of Manchester, Manchester, UK.ORCID https://orcid.org/0000-0002-9837-0645
Phyo K MyintAgeing Clinical & Experimental Research (ACER) Team, Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK.ORCID https://orcid.org/0000-0003-3852-6158
Olivia RendoraPrescribing Observatory for Mental Health, Royal College of Psychiatrists, London, UK.ORCID https://orcid.org/0000-0002-7843-3426
Elena M Edokpolor PerniaPrescribing Observatory for Mental Health, Royal College of Psychiatrists, London, UK.
Carol PatonDivision of Psychiatry, Imperial College London, London, UK.ORCID https://orcid.org/0000-0001-7756-1031

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMedications with anticholinergic properties are associated with a range of adverse effects that tend to be worse in older people.

aimsTo investigate medication regimens with high anticholinergic burden, prescribed for older adults under the care of mental health services.

methodClinical audit of prescribing practice, using a standardised data collection tool.

resultsFifty-seven trusts/healthcare organisations submitted data on medicines prescribed for 7915 patients: two-thirds (66%) were prescribed medication with anticholinergic properties, while just under a quarter (23%) had a medication regimen with high anticholinergic burden (total score ≥3 on the anticholinergic effect on cognition (AEC) scale). Some 16% of patients with a diagnosis of dementia or mild cognitive impairment were prescribed medication regimens with a high anticholinergic burden, compared with 35% of those without such diagnoses. A high anticholinergic burden was mostly because of combinations of commonly prescribed psychotropic medications, principally antidepressant and antipsychotic medications with individual AEC scores of 1 or 2.

conclusionsAdults under the care of older people's mental health services are commonly prescribed multiple medications for psychiatric and physical disorders; these medication regimens can have a high anticholinergic burden, often an inadvertent consequence of the co-prescription of medications with modest anticholinergic activity. Prescribers for older adults should assess the anticholinergic burden of medication regimens, assiduously check for adverse anticholinergic effects and consider alternative medications with less anticholinergic effect where indicated. The use of a scale, such as the AEC, which identifies the level of central anticholinergic activity of relevant medications, can be a helpful clinical guide.

Indexed as

Anticholinergicdementiamental healtholder adults

Identifiers

PMID39359152
PMCPMC11536223

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.